<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="/xsl/rss2.xsl"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>In Re: Ozempic (Semaglutide) Patent Litigation :: Justia Dockets &amp; Filings</title>
        <link>https://dockets.justia.com/docket/delaware/dedce/1:2022md03038/79694</link>
        <atom:link href="https://dockets.justia.com/docket/delaware/dedce/1:2022md03038/79694/feed" rel="self" type="application/rss+xml" />
        <pubDate>Fri, 10 Jul 2026 05:20:43 -0700</pubDate>
        <lastBuildDate>Fri, 10 Jul 2026 05:20:43 -0700</lastBuildDate>
        <generator>Justia Dockets &amp; Filings</generator>
        <copyright>Copyright 2026 Justia Inc</copyright>
        <description>In Re: Ozempic (Semaglutide) Patent Litigation - Docket Entries - Showing 1 through 127</description>
                                    <item>
        <title>
                            <![CDATA[Document 127]]>
                    </title>
                <description>
            <![CDATA[
                [SEALED] SO ORDERED, re (125 in 1:22-md-03038-CFC, 139 in 1:22-cv-00294-CFC) Stipulation of Dismissal As To Dr. Reddy's Laboratories, Ltd. And Dr. Reddy's Laboratories, Inc. Regarding The '154, '239, '611, '155, '063, And '363 Patents, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 5/11/2023.This order has been emailed to local counsel. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC(kmd) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917054</guid>
                <pubDate>
            Thu, 11 May 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 126]]>
                    </title>
                <description>
            <![CDATA[
                OBJECTIONS by Novo Nordisk A/S, Novo Nordisk Inc. to (89 in 1:22-cv-01040-CFC, 89 in 1:22-cv-01040-CFC) Answer to Amended Complaint, Counterclaim // Plaintiffs' Answer to Mylan Pharmaceuticals Inc.'s Counterclaims to First Amended Complaint. (Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917053</guid>
                <pubDate>
            Wed, 10 May 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 125]]>
                    </title>
                <description>
            <![CDATA[
                [SEALED] STIPULATION of Dismissal As To Dr. Reddy's Laboratories, Ltd. And Dr. Reddy's Laboratories, Inc. Regarding The '154, '239, '611, '155, '063, And '363 Patents by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917052</guid>
                <pubDate>
            Wed, 10 May 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 124]]>
                    </title>
                <description>
            <![CDATA[
                REDACTED VERSION of (137 in 1:22-cv-00294-CFC, 123 in 1:22-md-03038-CFC, 95 in 1:22-cv-01040-CFC) Appendix, by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: #1 Exs. A-L, #2 Exs. 1-14)(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917051</guid>
                <pubDate>
            Mon, 08 May 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 123]]>
                    </title>
                <description>
            <![CDATA[
                [SEALED] Joint APPENDIX re (119 in 1:22-md-03038-CFC) Joint Claim Construction Brief, (91 in 1:22-cv-01040-CFC) Joint Claim Construction Brief, (136 in 1:22-cv-00294-CFC) Joint Claim Construction Brief - by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: #1 Exs. A-L, #2 Exs. 1-14)(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917050</guid>
                <pubDate>
            Fri, 05 May 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                CORRECTING ENTRY: The Sealed Joint Appendix to the Joint Claim Construction Brief has been deleted as Exhibit K was blurry and difficult to read. A corrected version will be filed soon. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(nmf) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917049</guid>
                <pubDate>
            Fri, 05 May 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 122]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (93 in 1:22-cv-01040-CFC, 121 in 1:22-md-03038-CFC) STIPULATION TO EXTEND TIME for Novo Nordisk Inc. and Novo Nordisk A/S to respond to Mylan Pharmaceuticals Inc.'s Answer, Separate Defenses, and Counterclaims to First Amended Complaint to May 10, 2023, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 5/2/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-01040-CFC(kmd) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917048</guid>
                <pubDate>
            Tue, 02 May 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 121]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION TO EXTEND TIME for Novo Nordisk Inc. and Novo Nordisk A/S to respond to Mylan Pharmaceuticals Inc.'s Answer, Separate Defenses, and Counterclaims to First Amended Complaint to May 10, 2023 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917047</guid>
                <pubDate>
            Tue, 02 May 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 119]]>
                    </title>
                <description>
            <![CDATA[
                JOINT CLAIM CONSTRUCTION BRIEF - filed by Novo Nordisk Inc., Novo Nordisk A/S. (Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917046</guid>
                <pubDate>
            Mon, 01 May 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 118]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants' Sur-Reply Claim Construction Brief filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917045</guid>
                <pubDate>
            Thu, 27 Apr 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 117]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Alvogen, Inc.'s First Amended and Supplemental Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Alvogen, Inc..(DiBenedetto, Emily) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917044</guid>
                <pubDate>
            Tue, 25 Apr 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 116]]>
                    </title>
                <description>
            <![CDATA[
                ANSWER to Amended Complaint, re: #111 Amended Complaint , COUNTERCLAIM against Novo Nordisk A/S, Novo Nordisk Inc. by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917043</guid>
                <pubDate>
            Wed, 12 Apr 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 115]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of (1) Novo Nordisk's Reply Claim Construction Brief and (2) Declaration of Laura T. Moran in Support of Novo Nordisk A/S and Novo Nordisk Inc.'s Reply Claim Construction Brief - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917042</guid>
                <pubDate>
            Thu, 06 Apr 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 114]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION TO EXTEND TIME to Respond to Amended Complaint to April 12, 2023 - filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917040</guid>
                <pubDate>
            Tue, 04 Apr 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re #114 STIPULATION TO EXTEND TIME to Respond to Amended Complaint to April 12, 2023 filed by Mylan Pharmaceuticals Inc. Reset Answer Deadlines: Mylan Pharmaceuticals Inc. answer due 4/12/2023. Ordered by Judge Colm F. Connolly on 4/4/2023. (kmd) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917041</guid>
                <pubDate>
            Tue, 04 Apr 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 113]]>
                    </title>
                <description>
            <![CDATA[
                Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,114,833; 8,129,343; 8,536,122; ;8,684,969; 8,920,383; 9,108,002; ;9,132,239; 9,457,154; 9,616,180; ;9,687,611; 9,775,953; 9,861,757; ;10,220,155; 10,335,462; 10,357,616; ;10,376,652; 11,097,063; 11,311,679; ;11,446,443; and RE46,363 . (Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917039</guid>
                <pubDate>
            Wed, 22 Mar 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 112]]>
                    </title>
                <description>
            <![CDATA[
                Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than February 13, 2023 (as to Mylan Pharmaceuticals, Inc.'s ANDA No. 217706 added to the case in Plaintiffs' First Amended Complaint). Date of Expiration of Patent: U.S. Patent No. 8,114,833 expires on 8/13/2025; U.S. Patent Nos. 8,684,969 and 11,446,443 expire on 10/20/2025; U.S. Patent Nos. 9,108,002, 9,616,180, 9,861,757, 10,357,616, 10,376,652, and 11,311,679 expire on 1/20/2026; U.S. Patent No. 8,536,122 expires on 3/20/2026; Patent No. RE46,363 expires on 8/3/2026; U.S. Patent No. 9,687,611 expires on 2/27/2027; U.S. Patent Nos. 8,920,383, 9,775,953, 10,220,155, and 11,097,063 expire on 7/17/2026; U.S. Patent No. 9,457,154 expires on 9/27/2027; U.S. Patent No. 9,132,239 expires on 2/1/2032; U.S. Patent No. 8,129,343 expires on 12/5/2031.Thirty Month Stay Deadline: 8/13/2025. (Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917038</guid>
                <pubDate>
            Wed, 22 Mar 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                PATENT REPORT NOTICE: Please note that if patents are being added to this case, the filing party should complete the Report to Commissioner of Patents & Trademarks, and enter it on the docket using the PATENT/TRADEMARK REPORT event in the OTHER DOCUMENT list. The patent report form can be found at www.ded.uscourts.gov under the Clerk's Office FORMS button. (nmf) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917037</guid>
                <pubDate>
            Tue, 21 Mar 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 111]]>
                    </title>
                <description>
            <![CDATA[
                FIRST AMENDED COMPLAINT against Mylan Pharmaceuticals Inc.- filed by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: #1 Exhibit A)(kmd) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917036</guid>
                <pubDate>
            Tue, 21 Mar 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 110]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (82 in 1:22-cv-01040-CFC, 109 in 1:22-md-03038-CFC) Stipulation to Amend Complaint, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 3/21/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-01040-CFC(kmd) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917035</guid>
                <pubDate>
            Tue, 21 Mar 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 109]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION to Amend Complaint (D.I. 2 in 1:22-cv-01040-CFC) - by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: #1 Ex. 1 - First Amended Complaint, #2 Exs. A-T to First Amended Complaint, #3 Ex. 2 - Redline)(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917034</guid>
                <pubDate>
            Tue, 21 Mar 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 108]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of copies of (i) Defendants' Answering Claim Construction Brief; and, (ii) Declaration of Karl R. Leinsing, MSME, PE filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917033</guid>
                <pubDate>
            Fri, 17 Mar 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 107]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' Second Supplemental Disclosure of Asserted Patents and Claims as to DRL Defendants filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917032</guid>
                <pubDate>
            Tue, 07 Mar 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 106]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' Second Supplemental Disclosure of Asserted Patents and Claims as to Alvogen filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917031</guid>
                <pubDate>
            Tue, 07 Mar 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 105]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' First Amended Infringement Contentions Regarding the '343 Patent (Individual Sets Served on Each Defendant Group) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917030</guid>
                <pubDate>
            Mon, 06 Mar 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 104]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Novo Nordisk's Opening Claim Construction Brief - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917029</guid>
                <pubDate>
            Fri, 24 Feb 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 103]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' First Supplemental Disclosure of Asserted Patents and Claims as to RIO Defendants, Sun Defendants, Alvogen and DRL Defendants (separate disclosure sent to each defendant group) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917028</guid>
                <pubDate>
            Thu, 09 Feb 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 102]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' Second Supplemental Disclosure of Asserted Patents and Claims as to Zydus Defendants filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917027</guid>
                <pubDate>
            Thu, 09 Feb 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 101]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' First Supplemental Disclosure of Asserted Patents and Claims as to MPI filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917026</guid>
                <pubDate>
            Thu, 09 Feb 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                ORAL ORDER: Due to a conflict on the Court's calendar, the Markman Hearing is rescheduled for 7/13/2023 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Ordered by Judge Colm F. Connolly on 2/8/2023. Associated Cases: 1:22-md-03038-CFC et al.(nmf) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917025</guid>
                <pubDate>
            Wed, 08 Feb 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 100]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Claim Construction re (75 in 1:22-cv-01040-CFC, 123 in 1:22-cv-00294-CFC, 98 in 1:22-md-03038-CFC) Claim Construction Chart - filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917024</guid>
                <pubDate>
            Fri, 03 Feb 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 99]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Claim Construction re (75 in 1:22-cv-01040-CFC, 123 in 1:22-cv-00294-CFC, 98 in 1:22-md-03038-CFC) Claim Construction Chart - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917023</guid>
                <pubDate>
            Fri, 03 Feb 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 98]]>
                    </title>
                <description>
            <![CDATA[
                CLAIM Construction Chart by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: #1 Ex A - '383 Patent, #2 Ex B - '154 Patent, #3 Ex C - '953 Patent, #4 Ex D - '462 Patent)(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917022</guid>
                <pubDate>
            Fri, 03 Feb 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 97]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (73 in 1:22-cv-01040-CFC, 96 in 1:22-md-03038-CFC, 121 in 1:22-cv-00294-CFC) STIPULATION TO EXTEND TIME for Certain Claim Construction Deadlines to Various Dates, filed by Novo Nordisk A/S, Novo Nordisk Inc. Reset Deadlines for Claim Construction Briefing and Markman Hearing: Joint Claim Construction Chart due by 2/3/2023. Claim Construction Opening Brief due by 2/24/2023. Claim Construction Answering Brief due by 3/17/2023. Claim Construction Reply Brief due by 4/6/2023. Claim Construction Surreply Brief due by 4/26/2023. Signed by Judge Colm F. Connolly on 2/2/2023. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-01040-CFC(kmd) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917021</guid>
                <pubDate>
            Thu, 02 Feb 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 96]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION TO EXTEND TIME for Certain Claim Construction Deadlines to Various Dates - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917020</guid>
                <pubDate>
            Wed, 01 Feb 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 95]]>
                    </title>
                <description>
            <![CDATA[
                REDACTED VERSION of (116 in 1:22-cv-00294-CFC, 90 in 1:22-md-03038-CFC) Stipulation of Dismissal, by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Kraman, Pilar) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917019</guid>
                <pubDate>
            Tue, 31 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 94]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novo Nordisk Commercial Holdings, Inc., Other Affiliate Novo Nordisk A/S, Other Affiliate Novo Nordisk US Holdings Inc. for Novo Nordisk Inc.; Corporate Parent Novo Holdings A/S, Other Affiliate Novo Nordisk Foundation for Novo Nordisk A/S filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917018</guid>
                <pubDate>
            Tue, 31 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 93]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' Notice to Sun of Subpoena for Production of Documents (confidential as to Sun Pharmaceutical Industries Ltd. And Sun Pharmaceutical Industries, Inc.) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917017</guid>
                <pubDate>
            Fri, 27 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 92]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' Notice to Mylan of Subpoena for Production of Documents (confidential as to Mylan Pharmaceuticals Inc.) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917016</guid>
                <pubDate>
            Fri, 27 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 91]]>
                    </title>
                <description>
            <![CDATA[
                [SEALED] SO ORDERED, re (116 in 1:22-cv-00294-CFC, 90 in 1:22-md-03038-CFC) Stipulation of Dismissal as to Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited regarding the '383, '239, '154, '611, '953, '155, '063, and '363 Patents, filed by Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., Zydus Lifesciences Limited. Signed by Judge Colm F. Connolly on 1/27/2023.This order has been emailed to local counsel. Associated Cases: 1:22-cv-00294-CFC, 1:22-md-03038-CFC(kmd) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917015</guid>
                <pubDate>
            Fri, 27 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 90]]>
                    </title>
                <description>
            <![CDATA[
                [SEALED] STIPULATION of Dismissal as to Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited regarding the '383, '239, '154, '611, '953, '155, '063, and '363 Patents by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Kraman, Pilar) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917014</guid>
                <pubDate>
            Thu, 26 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 89]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' Proposed Claim Constructions - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20917013</guid>
                <pubDate>
            Wed, 25 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 88]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants Proposed Constructions and Intrinsic Evidence (with Exhibit A) filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916990</guid>
                <pubDate>
            Tue, 24 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 87]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of (1) Defendant Mylan Pharmaceuticals Inc.s Objections and Responses to Plaintiffs Third Set of Requests for the Production of Documents and Things (Nos. 163-168) and (2) Defendant Mylan Pharmaceuticals Inc.s Objections and Responses to Third Set of Collective Interrogatories (No 14) filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916989</guid>
                <pubDate>
            Mon, 23 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 86]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of 1. Alvogen's Responses and Objections to Plaintiffs' Third Set of Requests for the Production of Documents and Things (Nos. 89-94) 2. Alvogen's Responses and Objections to Plaintiffs' Third Set of Collective Interrogatories (No. 14) filed by Alvogen, Inc..(Keller, Karen) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916988</guid>
                <pubDate>
            Mon, 23 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 85]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of (1) Sun's Responses and Objections to Plaintiffs' Third Set of Collective Interrogatories (No. 14) and (2) Sun's Responses and Objections to Plaintiffs' Third Set of Requests for the Production of Documents and Things (Nos. 77-82) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Metzler, Sara) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916987</guid>
                <pubDate>
            Mon, 23 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 84]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of (i) DRL's Objections and Responses to Plaintiffs' Third Set of Collective Interrogatories to Defendants (No. 14); and, (ii) DRL's Responses and Objections to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 95-100) filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories Inc..(Gattuso, Dominick) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916986</guid>
                <pubDate>
            Mon, 23 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 83]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of 1) Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' Third Set of Collective Interrogatories to Defendants (No. 14); and 2) Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' Third Set of Requests for the Production of Documents and Things (Nos. 74-91) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916985</guid>
                <pubDate>
            Mon, 23 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 82]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of (1) Defendants Rio Biopharmaceuticals Inc. and EMS S/A's response to Plaintiffs' Third Set of Collective Interrogatories (No. 14); and (2) Defendants Rio Biopharmaceuticals Inc. and EMS S/A's response to Plaintiffs' Third Set of Requests for Production (Nos. 93-98) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916984</guid>
                <pubDate>
            Mon, 23 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 81]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' Identification of Inventors Employed by Plaintiffs and/or Represented by Counsel for Plaintiffs - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916983</guid>
                <pubDate>
            Thu, 19 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 80]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants' List of Proposed Terms for Construction filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories Inc..(Gattuso, Dominick) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916982</guid>
                <pubDate>
            Fri, 13 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 79]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' Preliminary Identification of Claim Terms Requiring Construction Pursuant to Paragraph 19 of the Scheduling Order (C.A. No. 22-294-CFC at D.I. 22; C.A. No. 22-1040-CFC at D.I. 53) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916981</guid>
                <pubDate>
            Thu, 12 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 78]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (77 in 1:22-md-03038-CFC, 64 in 1:22-cv-01040-CFC, 104 in 1:22-cv-00294-CFC) Stipulation to Extend Certain Claim Construction Deadlines, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 1/4/2023. Associated Cases: 1:22-cv-01040-CFC, 1:22-cv-00294-CFC, 1:22-md-03038-CFC(kmd) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916980</guid>
                <pubDate>
            Wed, 04 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 77]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION and [Proposed] Order to Extend Certain Claim Construction Deadlines - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916979</guid>
                <pubDate>
            Wed, 04 Jan 2023 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 76]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' Third Set of Requests for the Production of Documents and Things (Individual Requests Served on Each Defendant Group) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916978</guid>
                <pubDate>
            Thu, 22 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 75]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' Third Set of Collective Interrogatories to Defendants (No. 14) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916977</guid>
                <pubDate>
            Thu, 22 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 74]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' Third Set of Requests for the Production of Documents and Things (Nos. 163-168) Directed to Defendant Mylan Pharmaceuticals, Inc. filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916976</guid>
                <pubDate>
            Thu, 22 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 73]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Novo Nordisk's Initial Responses to Defendants' Initial Invalidity Contentions Regarding U.S. Patent Nos. 8,129,343; 8,536,122; 8,114,833; 8,920,383; 9,775,953; 9,457,154; and 10,335,462 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916975</guid>
                <pubDate>
            Wed, 21 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 72]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.s Objections and Responses to Second Set of Collective Interrogatories (No. 13) filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916974</guid>
                <pubDate>
            Fri, 16 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 71]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions (Individual Sets Served on Each Defendant Group) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916973</guid>
                <pubDate>
            Fri, 16 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 70]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs Second Set of Collective Interrogatories to Defendants (No. 13) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916972</guid>
                <pubDate>
            Fri, 16 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 69]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Alvogen's Responses and Objections to Plaintiffs' Second Set of Collective Interrogatories to Defendants (No. 13) filed by Alvogen, Inc..(Keller, Karen) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916971</guid>
                <pubDate>
            Fri, 16 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 68]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Suns Responses and Objections to Plaintiffs Second Set of Collective Interrogatories (No. 13) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Metzler, Sara) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916970</guid>
                <pubDate>
            Fri, 16 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 67]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants Rio Biopharmaceuticals Inc. and EMS S/A's responses to Plaintiff's Second Set of Collective Interrogatories (No. 13) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916969</guid>
                <pubDate>
            Fri, 16 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 66]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of DRL's Objections and Responses to Plaintiffs' Second Set of Collective Interrogatories to Defendants (No. 13) filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916968</guid>
                <pubDate>
            Thu, 15 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 65]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE of Appearance by Alexis Stombaugh on behalf of Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC (Stombaugh, Alexis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916967</guid>
                <pubDate>
            Thu, 08 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 64]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' First Supplemental Disclosure of Asserted Patents and Claims as to Zydus Defendants - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916966</guid>
                <pubDate>
            Thu, 01 Dec 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 63]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.s First Supplemental Objections and Responses to Plaintiffs First Set of Requests for the Production of Documents and Things (Nos. 1-10) filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916965</guid>
                <pubDate>
            Wed, 30 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 62]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of (1) Plaintiffs' Response to Defendants' First Set of Interrogatories (Nos. 1-4); and (2) Plaintiffs' Response to Defendants' First Set of Requests for Production (Nos. 1-23) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916964</guid>
                <pubDate>
            Tue, 22 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 61]]>
                    </title>
                <description>
            <![CDATA[
                REDACTED VERSION of (87 in 1:22-cv-00294-CFC, 57 in 1:22-md-03038-CFC) Stipulation of Dismissal by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916963</guid>
                <pubDate>
            Mon, 21 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 60]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants' Identification of Prior Art to Supplement Defendants' Initial Invalidity Contentions filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916962</guid>
                <pubDate>
            Fri, 18 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 59]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' Second Set of Collective Interrogatories to Defendants (No. 13) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916961</guid>
                <pubDate>
            Wed, 16 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Remark: Docket text of Order (87 in 1:22-cv-00294-CFC, 57 in 1:22-md-03038-CFC) corrected. Party Alvogen, Inc. and attorneys reinstated in cases. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC(kmd) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916960</guid>
                <pubDate>
            Wed, 16 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 58]]>
                    </title>
                <description>
            <![CDATA[
                [SEALED] SO ORDERED, re (87 in 1:22-cv-00294-CFC, 57 in 1:22-md-03038-CFC) Stipulation of Dismissal as to Alvogen, Inc. Regarding the '239, '611, '155, '063, and '363 Patents (Joint), filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 11/15/2022.This order has been emailed to local counsel. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC(kmd) Modified on 11/16/2022 (kmd). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916959</guid>
                <pubDate>
            Tue, 15 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 57]]>
                    </title>
                <description>
            <![CDATA[
                [SEALED] STIPULATION of Dismissal as to Alvogen, Inc. Regarding the '239, '611, '155, '063, and '363 Patents (Joint) by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916958</guid>
                <pubDate>
            Mon, 14 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 56]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.s Objections and Responses to First Set of Collective Interrogatories (Nos. 1-12) filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916957</guid>
                <pubDate>
            Thu, 10 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 55]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (52 in 1:22-cv-01040-CFC, 52 in 1:22-md-03038-CFC) PROPOSED ORDER Adopting Scheduling Order, Protective Order and ESI Order. Signed by Judge Colm F. Connolly on 11/9/2022. (nmf) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916956</guid>
                <pubDate>
            Wed, 09 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 54]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of (1) Plaintiffs' First Amended Disclosures Under Paragraph 3 of the District of Delaware Default Standard to the Sun Defendants and (2) Plaintiffs' First Amended Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure to the Sun Defendants - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916955</guid>
                <pubDate>
            Tue, 08 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 53]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of (1) Plaintiffs' First Amended Disclosures to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and (2) Plaintiffs' First Amended Disclosures to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited Under Paragraph 3 of the District of Delaware Default Standard - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916954</guid>
                <pubDate>
            Tue, 08 Nov 2022 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 52]]>
                    </title>
                <description>
            <![CDATA[
                PROPOSED ORDER Adopting Scheduling Order, Protective Order and ESI Order by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916953</guid>
                <pubDate>
            Fri, 04 Nov 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 51]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11-73) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916952</guid>
                <pubDate>
            Thu, 03 Nov 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 50]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.s Objections and Responses to Plaintiffs Second Set of Requests for the Production of Documents and Things (Nos. 11-162) filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916951</guid>
                <pubDate>
            Thu, 27 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 49]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendant's Responses and Objections to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11 - 88) filed by Alvogen, Inc..(Hoeschen, Nathan) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916950</guid>
                <pubDate>
            Thu, 27 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 48]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of DRL's Responses and Objections to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11-94) filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916949</guid>
                <pubDate>
            Thu, 27 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 47]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Suns Responses and Objections to Plaintiffs Second Set of Requests for the Production of Documents and Things (Nos. 11-76) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Farnan, Kelly) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916948</guid>
                <pubDate>
            Thu, 27 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 46]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of DEFENDANTS RIO BIOPHARMACEUTICALS INC. AND EMS S/AS OBJECTIONS AND RESPONSES TO PLAINTIFFS SECOND SET OF REQUESTS FOR PRODUCTION OF DOCUMENTS (NOS. 11-92) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Hitch, Cortlan) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916947</guid>
                <pubDate>
            Thu, 27 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 45]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants First Set of Interrogatories to Plaintiffs and Defendants First Set of Requests for Production to Plaintiffs filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916946</guid>
                <pubDate>
            Fri, 21 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (78 in 1:22-cv-00294-CFC, 42 in 1:22-md-03038-CFC) MOTION for Pro Hac Vice Appearance of Attorney Aaron Z. Savit, filed by Alvogen, Inc. Ordered by Judge Colm F. Connolly on 10/21/2022. Associated Cases: 1:22-cv-00294-CFC, 1:22-md-03038-CFC(kmd) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916944</guid>
                <pubDate>
            Fri, 21 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Pro Hac Vice Attorney Aaron Z. Savit for Alvogen, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916945</guid>
                <pubDate>
            Fri, 21 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 44]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants Noninfringement Contentions filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916943</guid>
                <pubDate>
            Thu, 20 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 43]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Initial Invalidity Contentions filed by Sun Pharmaceutical Industries Inc., Sun Pharmaceutical Industries Ltd..(Metzler, Sara) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916942</guid>
                <pubDate>
            Thu, 20 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 42]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Pro Hac Vice Appearance of Attorney Aaron Z. Savit - filed by Alvogen, Inc.. (Hoeschen, Nathan) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916941</guid>
                <pubDate>
            Thu, 20 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 41]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Alvogen, Inc.'s Preliminary Non-Infringement Contentions filed by Alvogen, Inc..(Hoeschen, Nathan) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916924</guid>
                <pubDate>
            Thu, 20 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 40]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Sun's Initial Non-Infringement Contentions filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Farnan, Kelly) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916923</guid>
                <pubDate>
            Thu, 20 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 39]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of copy of DRL's Noninfringement Contentions [CONFIDENTIAL] filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916922</guid>
                <pubDate>
            Thu, 20 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 38]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Initial Noninfringement Contentions filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916921</guid>
                <pubDate>
            Thu, 20 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 37]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants Rio Biopharmaceuticals Inc. and EMS S/A's Noninfringement Contentions Regarding Claims 12-14 of the '154 Patent filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916920</guid>
                <pubDate>
            Thu, 20 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 36]]>
                    </title>
                <description>
            <![CDATA[
                [SEALED] SO ORDERED, re (70 in 1:22-cv-00294-CFC, 34 in 1:22-md-03038-CFC) Stipulation of Dismissal as to Rio Biopharmaceuticals Inc. and EMS S/A Regarding the '239 and '611 Patents, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 10/20/2022.This order has been emailed to local counsel. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC(kmd) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916919</guid>
                <pubDate>
            Thu, 20 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 35]]>
                    </title>
                <description>
            <![CDATA[
                REDACTED VERSION of (70 in 1:22-cv-00294-CFC, 34 in 1:22-md-03038-CFC) Stipulation - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916918</guid>
                <pubDate>
            Wed, 19 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 34]]>
                    </title>
                <description>
            <![CDATA[
                [SEALED] STIPULATION and [Proposed] Order of Dismissal as to Rio Biopharmaceuticals Inc. and EMS S/A Regarding the '239 and '611 Patents - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916917</guid>
                <pubDate>
            Wed, 19 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 33]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE of Withdrawal of Joshua S. Reisberg by Alvogen, Inc. (Keller, Karen) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916916</guid>
                <pubDate>
            Fri, 14 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 32]]>
                    </title>
                <description>
            <![CDATA[
                ANSWER to Amended Complaint, re: #25 Amended Complaint by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916915</guid>
                <pubDate>
            Thu, 13 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 31]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' First Set of Collective Interrogatories to Defendants (Nos. 1-12) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916914</guid>
                <pubDate>
            Tue, 11 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 30]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants Rio Biopharmaceuticals Inc. and EMS S/A's responses to Plaintiff's First Set of Collective Interrogatories (Nos. 1-12) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916913</guid>
                <pubDate>
            Fri, 07 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 29]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants Responses to Plaintiffs First Set of Collective Interrogatories (Nos. 1-12) filed by Alvogen, Inc..(Keller, Karen) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916912</guid>
                <pubDate>
            Fri, 07 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 28]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of DRL's Objections and Responses to Plaintiffs' First Set of Collective Interrogatories to Defendants (Nos. 1-12) filed by Dr. Reddy's Laboratories Inc..(Gattuso, Dominick) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916911</guid>
                <pubDate>
            Fri, 07 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 27]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Suns Responses and Objections to Plaintiffs First Set of Collective Interrogatories to Defendants (Nos. 1-12) filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Farnan, Kelly) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916910</guid>
                <pubDate>
            Fri, 07 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 26]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' First Set of Collective Interrogatories to Defendants (Nos. 1-12) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_20916909</guid>
                <pubDate>
            Fri, 07 Oct 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 25]]>
                    </title>
                <description>
            <![CDATA[
                FIRST AMENDED COMPLAINT against Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC- filed by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: #1 Exhibit A-J)(kmd) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946976</guid>
                <pubDate>
            Thu, 29 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 24]]>
                    </title>
                <description>
            <![CDATA[
                ORDER granting ((23) in case 1:22-md-03038-CFC, (61) in case 1:22-cv-00294-CFC) Motion for Leave to File Amended Complaint Against Zydus (Unopposed). Signed by Judge Colm F. Connolly on 9/29/2022. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC(kmd) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946975</guid>
                <pubDate>
            Thu, 29 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 23]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Leave to File Amended Complaint Against Zydus (Unopposed) - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: #1 Ex. 1 - First Amended Complaint, #2 Exhibits A-J to First Amended Complaint, #3 Ex. 2 - Redline)(Egan, Brian) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946974</guid>
                <pubDate>
            Wed, 28 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Pro Hac Vice Attorney Aziz Burgy for Alvogen, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC(mpb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946973</guid>
                <pubDate>
            Wed, 28 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 22]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of (1) Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11-88) Directed to Defendant Alvogen, Inc., (2) Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11-94) Directed to Defendants Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc., (3) Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11-92) Directed to Defendants Rio Biopharmaceuticals Inc. and EMS S/A, (4) Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11-76) Directed to Defendants Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc., and (5) Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11-73) Directed to Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946972</guid>
                <pubDate>
            Tue, 27 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 21]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 11-162) Directed to Defendant Mylan Pharmaceuticals, Inc. - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946971</guid>
                <pubDate>
            Tue, 27 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 20]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Pro Hac Vice Appearance of Attorney Aziz Burgy - filed by Alvogen, Inc.. (Keller, Karen) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946969</guid>
                <pubDate>
            Tue, 27 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (59 in 1:22-cv-00294-CFC, 20 in 1:22-md-03038-CFC) MOTION for Pro Hac Vice Appearance of Attorney Aziz Burgy, filed by Alvogen, Inc. Ordered by Judge Colm F. Connolly on 9/27/2022. Associated Cases: 1:22-cv-00294-CFC, 1:22-md-03038-CFC(kmd) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946970</guid>
                <pubDate>
            Tue, 27 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 19]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.s Objections and Responses to Plaintiffs First Set of Requests for the Production of Documents and Things (Nos. 1-10) filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946968</guid>
                <pubDate>
            Fri, 09 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 18]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' First Set of Collective Interrogatories to Defendants (Nos. 1-12) - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946967</guid>
                <pubDate>
            Wed, 07 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Pro Hac Vice Attorney Bryan D. Beel for Mylan Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946966</guid>
                <pubDate>
            Wed, 07 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Pro Hac Vice Attorney Shannon M. Bloodworth for Mylan Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946965</guid>
                <pubDate>
            Wed, 07 Sep 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (17 in 1:22-md-03038-CFC, 44 in 1:22-cv-01040-CFC) MOTION for Pro Hac Vice Appearance of Attorney Jonathan I. Tietz, Shannon M. Bloodworth, Emily J. Greb, Michael R. Laing, and Bryan D. Beel, Ph.D., filed by Mylan Pharmaceuticals Inc. Ordered by Judge Colm F. Connolly on 8/30/2022. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-01040-CFC(kmd) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946964</guid>
                <pubDate>
            Tue, 30 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 17]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Pro Hac Vice Appearance of Attorney Jonathan I. Tietz, Shannon M. Bloodworth, Emily J. Greb, Michael R. Laing, and Bryan D. Beel, Ph.D. - filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946963</guid>
                <pubDate>
            Mon, 29 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 16]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.s Initial Disclosures Pursuant to the Delaware Default Standard for Discovery filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946962</guid>
                <pubDate>
            Fri, 26 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 15]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' Preliminary Disclosure of Asserted Patents and Claims filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946961</guid>
                <pubDate>
            Fri, 26 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 14]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of (1) Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard; and (2) Plaintiffs' Preliminary Disclosure of Asserted Patents and Claims filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946960</guid>
                <pubDate>
            Fri, 26 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 13]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE of Appearance by Richard Charles Weinblatt on behalf of Mylan Pharmaceuticals Inc. (Weinblatt, Richard) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946959</guid>
                <pubDate>
            Thu, 25 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 12]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE of Appearance by Stamatios Stamoulis on behalf of Mylan Pharmaceuticals Inc. (Stamoulis, Stamatios) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946958</guid>
                <pubDate>
            Thu, 25 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 11]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran, Erica R. Sutter and Olivia L. Wheeling - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946956</guid>
                <pubDate>
            Mon, 22 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (39 in 1:22-cv-01040-CFC, 11 in 1:22-md-03038-CFC) MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran, Erica R. Sutter and Olivia L. Wheeling, filed by Novo Nordisk A/S, Novo Nordisk Inc. Ordered by Judge Colm F. Connolly on 8/22/2022. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-01040-CFC(kmd) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946957</guid>
                <pubDate>
            Mon, 22 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 10]]>
                    </title>
                <description>
            <![CDATA[
                ANSWER to Complaint / Counterclaims -- Plaintiffs' Answer to Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Inc.'s Counterclaims -- by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946955</guid>
                <pubDate>
            Fri, 19 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 9]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' Amended Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946954</guid>
                <pubDate>
            Fri, 12 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 8]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendant's Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-10) filed by Alvogen, Inc..(Hoeschen, Nathan) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946953</guid>
                <pubDate>
            Thu, 11 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 7]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-10) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Kraman, Pilar) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946952</guid>
                <pubDate>
            Thu, 11 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 6]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-10) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946951</guid>
                <pubDate>
            Wed, 10 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 5]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of DRL's Responses and Objections to Plaintiffs' First Requests for the Production of Documents and Things (Nos. 1-10) Directed to DRL filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd..(Gattuso, Dominick) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946950</guid>
                <pubDate>
            Wed, 10 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 4]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of Defendants Rio Biopharmaceuticals Inc. and EMS S/A's responses to Plaintiff's First Set of Requests for Production (Nos. 1-10) filed by EMS S/A, Rio Biopharmaceuticals, Inc..(Dorsney, Kenneth) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17946949</guid>
                <pubDate>
            Wed, 10 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 3]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE of Appearance by Brian P. Egan on behalf of Novo Nordisk A/S, Novo Nordisk Inc. (Egan, Brian) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17331282</guid>
                <pubDate>
            Mon, 08 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 2]]>
                    </title>
                <description>
            <![CDATA[
                Letter to Clerk, USDC/NDWV from Clerk, USDC/DE, dated 08/05/2022, regarding transfer of Civil Action to Delaware. (smg) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17331281</guid>
                <pubDate>
            Fri, 05 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 1]]>
                    </title>
                <description>
            <![CDATA[
                CERTIFIED TRANSFER ORDER - issued by the Panel on Multi-District Litigation on 08/05/2022 - Associated DE Cases: CA 22-cv-294-CFC, CA 22-cv-296-CFC, CA 22-cv-297-CFC, CA 22-cv-298-CFC, CA 22-cv-299-CFC. (smg) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17331277</guid>
                <pubDate>
            Fri, 05 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                The following cases in the District of Delaware are included in this MDL: 1:22-cv-00294-CFC, 1:22-cv-00296-CFC, 1:22-cv-00297-CFC, 1:22-cv-00298-CFC, 1:22-cv-00299-CFC. (smg) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17331280</guid>
                <pubDate>
            Fri, 05 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE: Documents relating to all actions should be filed on the master docket sheet and on the docket sheet of each individual action. Documents relating to two or more, but not all, individual actions should be filed on the master docket sheet, and on the docket sheet of each affected individual action. Documents affecting a single individual action should be filed on the docket sheet of that action and on the master docket sheet. Associated Cases: 1:22-md-03038-CFC, 1:22-cv-00294-CFC, 1:22-cv-00296-CFC, 1:22-cv-00297-CFC, 1:22-cv-00298-CFC, 1:22-cv-00299-CFC.(smg) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17331279</guid>
                <pubDate>
            Fri, 05 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE TO COUNSEL: MDL No. 1:2022-md-3038 has been opened and assigned to the Honorable Colm F. Connolly. Attorneys of record who will be electronically filing documents may request E-Filing rights through PACER and add the MDL case number in the comments section of your request. Please see the docket for further entries. Associated Cases: 1:22-md-03038-CFC et al.(smg) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_17331278</guid>
                <pubDate>
            Fri, 05 Aug 2022 00:00:00 -0700
        </pubDate>
    </item>
                </channel>
</rss>
